BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH CALSCALE:GREGORIAN PRODID:iCalendar-Ruby BEGIN:VEVENT LOCATION:1 Hampshire Street\, Cambridge\, MA SEQUENCE:0 DTEND:20100208T203000 DTSTART:20100208T180000 UID:2012-02-09T23:59:22-05:00_929124287@tcs4.inetu.net DTSTAMP:20120209T235922 DESCRIPTION:LinktoEvent[0\,15]\n\nThe demand for better health care outcome s at lower costs is likely to increase over the next several years. One so lution to this need will be smart medical devices (SMDs)\, which sense key clinical parameters important to clinicians\, analyze these data\, and impl ement results &mdash\; either with clinical guidance or closed-loop. While some SMD-like devices already exist\, there is a tremendous opportunity fo r innovation. Over the course of the evening\, the panel of engineering\, clinical\, and industry experts will provide a view into the current status and future directions for SMDs.\n\nSupporting Organization: Massachusetts Life Sciences Center\n\nAgenda\n6:00 &ndash\; 6:30 pm - Re gistration/Networking/ Appetizers\n6:30 &ndash\; 6:45 pm - Opening Remarks\, BMES Leadership Team\n6:45 &ndash\; 8:00 pm - Panel: "Smart Medical Devices"\n8:00 &ndash\; 8:30 pm - Networking/Refreshments/Desserts\n \nPanelists\n\n -Edward Kerslake\, Vic e President\, Corporate Technology Development\, Boston Scientific\n\n -Dal e Larson\, Director\, Biomedical Systems Group\, Charles Stark Draper Labor atory\n\n -Dr. David Rattner\, Chief\, Division of General and Gastrointest inal Surgery\, Massachusetts General Hospital\n\nEvent Fee\nEarly bird: $10 by January 27\nRegular deadline: $15 by February 3\nOn-site registration: $20 (highly discouraged) \nLin ktoEvent[0\,15] \n--------------------------------------------------------- ---\n\nAbout Our Panelists\n\nEdward Kerslake\, Vice President Portfolio Ma nagement\, Corporate R&D at Boston Scientific\n Dr. Kerslake leads Boston S cientific's R&D portfolio-management process and the company's efforts to e nsure disciplined execution of its committed investments. Dr. Kerslake most recently held the position of EVP & COO at MDdatacor\, an innovative ventu re-backed cardiology company based in Atlanta\, Ga.\, and started by the fo under of WebMD. Previously\, he was a senior leader at the Monitor Group\, a global strategy consulting firm\, where his practice addressed the creati on and architecture of corporate and R&D strategies with clients in the pha rmaceutical\, device\, and broader life sciences industries. Before Monitor \, Dr. Kerslake worked in the pharmaceutical industry as senior scientist a nd as head of formulation for Allergan (NYSE:AGN) at its European R&D headq uarters in the south of France\, the R&D/manufacturing facility in Italy\, and subsequently at its headquarters in California. While at Allergan\, Dr Kerslake invented and holds the patents protecting Allergan's Alphagan P Gl aucoma portfolio (a ~$400M/yr suite of products). Qualified as a pharmacist in the United Kingdom\, Dr. Kerslake subsequently received a PhD in pharma ceutical sciences (controlled drug delivery - transdermal systems) and an M BA from the University of California\, Irvine.\n \nDale Larson\, Director\, Biomedical Systems Group\, Charles Stark Draper Laboratory\nDale Larson is director of the Biomedical Systems Group at the Charles Stark Draper Labor atory. Before joining Draper\, Larson spent more than seven years at Harva rd Medical School\, where he was the founding director of its Technology an d Engineering Center &mdash\; a group that has been pioneering in the devel opment of a variety of clinical diagnostics and advanced instrumentation fo r the life sciences. With previous tenures at companies including Arthur D. Little\, Genomics Collaborative\, Ortho Diagnostics Systems\, Thermedics\, Inc.\, and AT&T Bell Laboratories\, he has industry experience in the area s of genomics services\, instrumentation\, clinical diagnostics\, medical d evices\, and explosives detection.\n \nDr. David Rattner\, Chief\, Division of General and Gastrointestinal Surgery\, Massachusetts General Hospital\n David Rattner received his medical degree from the Johns Hopkins School of Medicine. After completing his residency in surgery at the Massachusetts Ge neral Hospital\, he joined the active clinical faculty\, where he is now ch ief of the Division of General and Gastrointestinal Surgery. In addition to pursuing research on minimally invasive surgery and technology transfer\, Dr. Rattner is a professor of surgery at Harvard Medical School. He has pub lished more than 150 original articles concerning pancreatic disease and bi liary disease\, gastroesophageal reflux disease\, and minimally invasive th erapy. \nAbout Our Sponsor: Charles Stark Draper Laboratory\n\nHeadquartere d in Cambridge\, Mass.\, Draper Laboratory is a research and development la boratory\, whose more than 850 engineers\, scientists\, and technicians &md ash\; among its 1\,384 employees &mdash\; work on a broad array of programs for government and commercial sponsors.\n\nIts sponsored work encompasses capabilities in the following business areas:\n\n -Strategic systems\n\n -S pace systems\n\n -Tactical systems\n\n -Special operations\n\n -Biomedical engineering\n\n -Geospatial solutions\n\n -Energy solutions\n\nThe Laborato ry's unparalleled expertise in the areas of guidance\, navigation\, and con trol systems remains its greatest resource. Draper is among the leaders in fault-tolerant computing\, reliable software development\, modeling and sim ulation\, and MEMS technology. It applies its expertise to a broad range of domains\, including autonomous air\, land\, sea\, and space systems\; info rmation integration\; distributed sensors and networks\; precision-guided m unitions\; air traffic flow management\; military logistics\; and biomedica l engineering and chemical/biological defense. \nAbout Our Chapter\n\nThe B iomedical Engineering Society\, Boston Industry Chapter\, was founded in Oc tober 2008 to develop a community that provides biomedical engineering (BME ) professionals with networking\, continuing education\, and technology-tra nsfer opportunities. Our mission is to:\n\n -serve as the lead society for BME professionals\n\n -expand the careers of current and next generation B MEs\n\n -educate the technical community regarding the expertise BMEs provi de to engineering and scientific fields\n\n -enhance the recognition of bio medical engineering as a discipline critical to the continued improvement o f human health\n\nCheck out our website: BMES Industry Chapters. Please con tact Andrea Ippolito ((mailto:bmesprofessional@gmail.com) bmesprofessional@ gmail.com) or the BMES office at (mailto:regina.borkoski@bmes.org) regina.b orkoski@bmes.org if you have any questions. \nDirections to Draper Laborato ry\n\n(http://draper.com/directions/directions.html) http://draper.com/dire ctions/directions.html\nParking is available in the Technology Square garag e across from the Draper visitor entrance. It is the second garage entrance on the right from the Broadway entrance to Tech Square. SUMMARY:Smart Medical Devices Panel Discussion END:VEVENT END:VCALENDAR